E-viri
PDF
Recenzirano
Odprti dostop
-
Schommers, Philipp; Hentrich, Marcus; Hoffmann, Christian; Gillor, Daniel; Zoufaly, Alexander; Jensen, Björn; Bogner, Johannes R.; Thoden, Jan; Wasmuth, Jan‐Christian; Wolf, Timo; Oette, Mark; Müller, Markus; Esser, Stefan; Vehreschild, Jörg J.; Fätkenheuer, Gerd; Wyen, Christoph
British journal of haematology, March 2015, 2015-Mar, 2015-03-00, 20150301, Letnik: 168, Številka: 6Journal Article
Summary Overall survival (OS) of patients with acquired immunodeficiency syndrome (AIDS)‐related Burkitt lymphoma (BL), diffuse large B‐cell lymphoma (DLBCL) and plasmablastic lymphoma (PBL) was analysed in the German AIDS‐related‐Lymphoma‐Cohort‐Study. Of 291 patients prospectively included between January 2005 and December 2012, 154 had DLBCL, 103 BL and 34 PBL. Two‐year OS rates were similar between BL (69%) and DLBCL patients (63%) but lower for PBL patients (43%). Intermediate (Hazard ratio HR 4·1 95% confidence interval CI 1·98–8·49) or high (HR 4·92 95% CI 2·1–11·61) International Prognostic Index, bone marrow involvement (HR 1·69 95% CI 1·00–2·84) and PBL histology (HR 2·24 95% CI 1·24–4·03) were independent predictors of mortality.
